drugset / Trial / NCT03618225

Duloxetine Role in Reducing Opioid Consumption After Thoracotomy

NCT03618225

Phase 4 Completed 60 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

A total of 60 patients scheduled for thoracotomy with the aim of excision of pleural or lung cancer, will be randomized by the use of a computer-generated table of random numbers to receive duloxetine 60 mg orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure or a placebo pill following the same time schedule.

Timeline

Start
2018-08-15
Primary completion
2020-01-31
Completion
2020-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Duloxetine Small molecule 60 mg Oral

Indications

No indication recorded.